SNN
Smith & Nephew SNATS Inc
NYSE: SNN · HEALTHCARE · MEDICAL DEVICES
$30.12
+0.07% today
Updated 2026-10-28
Market cap
$12.90B
P/E ratio
20.97
P/S ratio
2.05x
EPS (TTM)
$1.47
Dividend yield
2.58%
52W range
$26 – $36
Volume
1.5M
Smith & Nephew SNATS Inc (SNN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$30.12
12-Month target
$32.39
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2B | $5.2B | $5.5B | $5.8B | $6.2B | $6.5B | $7.0B | $7.4B | $7.8B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 6.21% (capped 20%) · P/E: 20.97x (capped 25x) · Margin: 10.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.